The DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index, and 1 are not checked yet.
In silico toxicology protocols
Open accessAbstract
The present publication surveys several applications of in silico (i.e., computational) toxicology approaches across different industries and institutions. It highlights the need to develop standardized protocols when conducting toxicity-related predictions. This contribution articulates the information needed for protocols to support in silico predictions for major toxicological endpoints of concern (e.g., genetic toxicity, carcinogenicity, acute toxicity, reproductive toxicity, developmental toxicity) across several industries and regulatory bodies. Such novel in silico toxicology (IST) protocols, when fully developed and implemented, will ensure in silico toxicological assessments are performed and evaluated in a consistent, reproducible, and well-documented manner across industries and regulatory bodies to support wider uptake and acceptance of the approaches. The development of IST protocols is an initiative developed through a collaboration among an international consortium to reflect the state-of-the-art in in silico toxicology for hazard identification and characterization. A general outline for describing the development of such protocols is included and it is based on in silico predictions and/or available experimental data for a defined series of relevant toxicological effects or mechanisms. The publication presents a novel approach for determining the reliability of in silico predictions alongside experimental data. In addition, we discuss how to determine the level of confidence in the assessment based on the relevance and reliability of the information.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
QSAR Modeling: Where have you been? Where are you going to?
Cherkasov, A., Muratov, E. N., Fourches, D., Varnek, A., Baskin, I. I., Cronin, M., Dearden, J., Gramatica, P., Martin, Y. C., Todeschini, R., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4004285 · Cited by 2,164
Self-citationA strategy for structuring and reporting a read-across prediction of toxicity
Schultz, T. W., Amcoff, P., Berggren, E., Gautier, F., Klarić, M., Knight, D. J., Mahony, C., Schwarz, M. H., White, A., & Cronin, M. (2015) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2015.05.016 · Cited by 1,595
Self-citationReference Module in Chemistry, Molecular Sciences and Chemical Engineering
(2014) · Choice Reviews Online · doi:10.5860/choice.51-6506 · Cited by 1,354
Klimisch, H.-J., Andreae, M. O., & Tillmann, U. (1997) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.1996.1076 · Cited by 1,167
Netzeva, T. I., Worth, A. P., Aldenberg, T., Benigni, R., Cronin, M., Gramatica, P., Jaworska, J. S., Kahn, S. D., Klopman, G., Marchant, C. A., et al. (2005) · Alternatives to Laboratory Animals · doi:10.1177/026119290503300209 · Cited by 840
Self-citationIn silico toxicology: computational methods for the prediction of chemical toxicity
Raies, A. B., & Bajić, V. B. (2016) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1240 · Cited by 756
OECD Guidelines for Testing of Chemicals
Maibach, H. I., & Wilhelm, K. (2007) · Informa Healthcare eBooks · doi:10.1201/9781420009774.ch33 · Cited by 506
“ToxRTool”, a new tool to assess the reliability of toxicological data
Schneider, K., Schwarz, M., Burkholder, I., Kopp‐Schneider, A., Edler, L., Kinsner‐Ovaskainen, A., Härtung, T., & Hoffmann, S. (2009) · Toxicology Letters · doi:10.1016/j.toxlet.2009.05.013 · Cited by 469
Rooney, A. A., Boyles, A. L., Wolfe, M. S., Bucher, J. R., & Thayer, K. A. (2014) · Environmental Health Perspectives · doi:10.1289/ehp.1307972 · Cited by 434
Authority, E. F. S. (2011) · EFSA Journal · doi:10.2903/j.efsa.2011.2092 · Cited by 224
Research works printed but not linked: 1
- EFSA, 2016, Guidance on the establishment of the residue definition for dietary risk assessment: EFSA Panel on Plant Protection Products and their Residues (PPR), EFSA J., 14, 1
Cited by
Sorted by citations
Muratov, E. N., Bajorath, J., Sheridan, R. P., Tetko, I. V., Filimonov, D., Poroikov, V., Oprea, T. I., Baskin, I. I., Varnek, A., Roitberg, A., et al. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00098a · Cited by 913
Self-citationArtificial Intelligence for Drug Discovery: Are We There Yet?
Hasselgren, C., & Oprea, T. I. (2024) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-040323-040828 · Cited by 236
Self-citationAlternative Strategies for Microbial Remediation of Pollutants via Synthetic Biology
Jaiswal, S., & Shukla, P. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00808 · Cited by 195
Hemmerich, J., & Ecker, G. F. (2020) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1475 · Cited by 175
TCRD and pharos 2021: mining the human proteome for disease biology
Sheils, T. K., Mathias, S. L., Kelleher, K. J., Siramshetty, V. B., Nguyen, D.-T., Bologa, C. G., Jensen, L. J., Vidović, D., Koleti, A., Schürer, S. C., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa993 · Cited by 160
Self-citation
Metadata
- Authors
- Myatt, G. J., Ahlberg, E., Akahori, Y., Allen, D., Amberg, A., Anger, L. T., Aptula, A., Auerbach, S., Beilke, L., Bellion, P., Benigni, R., Bercu, J., Booth, E. D., Bower, D., Brigo, A., Burden, N., Cammerer, Z., Cronin, M. T. D., Cross, K. P., Custer, L., Dettwiler, M., Dobo, K., Ford, K. A., Fortin, M. C., Gad-McDonald, S. E., Gellatly, N., Gervais, V., Glover, K. P., Glowienke, S., Van Gompel, J., Gutsell, S., Hardy, B., Harvey, J. S., Hillegass, J., Honma, M., Hsieh, J.-H., Hsu, C.-W., Hughes, K., Johnson, C., Jolly, R., Jones, D., Kemper, R., Kenyon, M. O., Kim, M. T., Kruhlak, N. L., Kulkarni, S. A., Kümmerer, K., Leavitt, P., Majer, B., Masten, S., Miller, S., Moser, J., Mumtaz, M., Muster, W., Neilson, L., Oprea, T. I., Patlewicz, G., Paulino, A., Lo Piparo, E., Powley, M., Quigley, D. P., Reddy, M. V., Richarz, A.-N., Ruiz, P., Schilter, B., Serafimova, R., Simpson, W., Stavitskaya, L., Stidl, R., Suarez-Rodriguez, D., Szabo, D. T., Teasdale, A., Trejo-Martin, A., Valentin, J.-P., Vuorinen, A., Wall, B. A., Watts, P., White, A. T., Wichard, J., Witt, K. L., Woolley, A., Woolley, D., Zwickl, C., & Hasselgren, C.
- Affiliations
- LeadScope (United States) (US)
- AstraZeneca (Sweden) (SE)
- Chemicals Evaluation and Research Institute (JP)
- Integrated Laboratory Systems, Inc. (US)
- Sanofi (Germany) (DE)
- Unilever (United Kingdom) (GB)
- National Institutes of Health (US)
- DSM (Switzerland) (CH)
- Gilead Sciences (United States) (US)
- Syngenta (United Kingdom) (GB)
- F. Hoffmann-La Roche AG (CH)
- National Centre for the Replacement Refinement and Reduction of Animals in Research (GB)
- Janssen Research & Development (United States) (US)
- Liverpool John Moores University (GB)
- Bristol-Myers Squibb (United States) (US)
- Pfizer (United States) (US)
- Rutgers, The State University of New Jersey (US)
- Defense Threat Reduction Agency (US)
- Novartis (Switzerland) (CH)
- GlaxoSmithKline (United Kingdom) (GB)
- National Institute of Health Sciences (JP)
- United States Food and Drug Administration (US)
- Leuphana University of Lüneburg (DE)
- Eli Lilly (United States) (US)
- Vertex Pharmaceuticals (United States) (US)
- Takeda (United States) (US)
- United States Department of Homeland Security (US)
- Agency for Toxic Substances and Disease Registry (US)
- British American Tobacco (United Kingdom) (GB)
- University of New Mexico (US)
- Environmental Protection Agency (US)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- European Commission (BE)
- European Food Safety Authority (IT)
- AstraZeneca (United Kingdom) (GB)
- UCB Pharma (Belgium) (BE)
- Colgate-Palmolive (United States) (US)
- Bibra International (GB)
- Corresponding author
- Myatt, Glenn J.
- ORCID
- Ahlberg, Ernst
- Allen, David
- Amberg, Alexander
- Aptula, Aynur
- Auerbach, Scott
- Beilke, Lisa
- Bellion, Phillip
- Benigni, Romualdo
- Bercu, Joel
- Bower, Dave
- Brigo, Alessandro
- Burden, Natalie
- Cronin, Mark T.D.
- Cross, Kevin P.
- Dobo, Krista
- Ford, Kevin A.
- Glowienke, Susanne
- Gutsell, Steve
- Hardy, Barry
- Harvey, James S.
- Hillegass, Jedd
- Honma, Masamitsu
- Johnson, Candice
- Jolly, Robert
- Kim, Marlene T.
- Kruhlak, Naomi L.
- Kulkarni, Sunil A.
- Kümmerer, Klaus
- Masten, Scott
- Miller, Scott
- Mumtaz, Moiz
- Muster, Wolfgang
- Oprea, Tudor I.
- Patlewicz, Grace
- Richarz, Andrea-Nicole
- Ruiz, Patricia
- Stavitskaya, Lidiya
- Szabo, David T.
- Teasdale, Andrew
- White, Angela T.
- Wichard, Joerg
- Witt, Kristine L.
- Woolley, Adam
- Woolley, David
- Venue
- Regulatory Toxicology and Pharmacology
- Publisher
- Elsevier BV
- Published
- 2018-07
- Volume
- 96
- Pages
- 1-17
- ISSN
- 0273-2300 (ISSN-L)
- PMC
- PMC6026539
- OpenAlex
- W2799297366
- Cited by
- 240
- References
- 60
- Citations by year
- 2026: 21 · 2025: 23 · 2024: 36 · 2023: 37 · 2022: 24 · 2021: 35 · 2020: 36 · 2019: 21 · 2018: 7
- FWCI
- 18.47
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Regulatory Toxicology and Pharmacology (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Multilingual Matters (Channel View Publications) (publishedVersion, cc-by)
- Liverpool John Moores University (acceptedVersion)
- PubMed Central (acceptedVersion)
- Joint Research Centre (European Commission) (submittedVersion)
- Funders
- National Institute of Environmental Health Sciences
- National Institutes of Health (R43ES026909)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Carcinogens and Genotoxicity Assessment
- Keywords
- computational toxicology, standardized protocols, toxicity prediction, genotoxicity, carcinogenicity, acute toxicity, reproductive toxicity, developmental toxicity, hazard identification, forecast reliability, confidence level, regulatory acceptance, reproducibility
- MeSH terms
- Animals, Computer Simulation, Humans, Toxicology, Toxicity Tests
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
